2022 - Research.com Biology and Biochemistry in Italy Leader Award
Marco Bianchi mainly investigates HMGB1, Cell biology, Inflammation, Chromatin and Molecular biology. His study with HMGB1 involves better knowledge in Immunology. His work in Cell biology covers topics such as Receptor which are related to areas like Pharmacology.
The study incorporates disciplines such as Extracellular, Secretion and Cancer research in addition to Inflammation. His Chromatin study incorporates themes from HMG-box, High-mobility group, Histone and Transcription factor. His Molecular biology research includes elements of Necrosis, Base pair, DNA and Cell nucleus.
Marco Bianchi spends much of his time researching Prostatectomy, Prostate cancer, Internal medicine, Urology and HMGB1. His study looks at the relationship between Prostatectomy and topics such as Surgery, which overlap with Nephrectomy. Marco Bianchi focuses mostly in the field of Prostate cancer, narrowing it down to topics relating to Lymph node and, in certain cases, Radiology.
Internal medicine is closely attributed to Oncology in his research. His HMGB1 research incorporates elements of RAGE, Cytokine and Cell biology. Marco Bianchi works mostly in the field of Cell biology, limiting it down to topics relating to Chromatin and, in certain cases, Molecular biology.
Marco Bianchi mostly deals with Pembrolizumab, Cystectomy, Condensed matter physics, Internal medicine and Cell biology. His work in Condensed matter physics tackles topics such as Photoemission spectroscopy which are related to areas like Angle-resolved photoemission spectroscopy, Molecular physics and Semiconductor. Within one scientific family, Marco Bianchi focuses on topics pertaining to Oncology under Internal medicine, and may sometimes address concerns connected to Prostate cancer, Prostatectomy and Confidence interval.
His biological study spans a wide range of topics, including Inflammation, HMGB1 and Transcription, Gene. Marco Bianchi combines subjects such as RAGE, Immune system and Monocyte with his study of Inflammation. His HMGB1 study combines topics from a wide range of disciplines, such as High-mobility group and Platelet.
His scientific interests lie mostly in HMGB1, Cystectomy, Pembrolizumab, Epitaxy and Cell biology. His HMGB1 research incorporates themes from Biophysics, Platelet and Cancer research. His Cystectomy research includes themes of Neoadjuvant therapy, Carcinoma and Oncology.
His Epitaxy research incorporates elements of Crystallography, Electronic structure, Photoemission spectroscopy, Electron diffraction and Scanning tunneling microscope. His Cell biology research is multidisciplinary, incorporating elements of Inflammation, Chromatin and Nuclear protein. His Inflammation research is multidisciplinary, incorporating perspectives in Receptor and Monocyte.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Paola Scaffidi;Tom Misteli;Marco E. Bianchi.
DAMPs, PAMPs and alarmins: all we need to know about danger
Marco E. Bianchi.
Journal of Leukocyte Biology (2007)
Bandgap opening in graphene induced by patterned hydrogen adsorption
Richard Balog;Bjarke Jørgensen;Louis Nilsson;Mie Andersen.
Nature Materials (2010)
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion
Tiziana Bonaldi;Fabio Talamo;Paola Scaffidi;Denise Ferrera.
The EMBO Journal (2003)
The nuclear protein HMGB1 is secreted by monocytes via a non‐classical, vesicle‐mediated secretory pathway
Stefania Gardella;Cristina Andrei;Denise Ferrera;Lavinia V Lotti.
EMBO Reports (2002)
Endogenous HMGB1 regulates autophagy
Daolin Tang;Rui Kang;Kristen M. Livesey;Chun-Wei Cheh.
Journal of Cell Biology (2010)
Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures
Mattia Maroso;Silvia Balosso;Teresa Ravizza;Jaron Liu.
Nature Medicine (2010)
Specific recognition of cruciform DNA by nuclear protein HMG1.
Marco E. Bianchi;Monica Beltrame;Giacomo Paonessa.
HMGB1 is an endogenous immune adjuvant released by necrotic cells
Patrizia Rovere‐Querini;Annalisa Capobianco;Paola Scaffidi;Barbara Valentinis.
EMBO Reports (2004)
High-Mobility Group Box-1 in Ischemia-Reperfusion Injury of the Heart
Martin Andrassy;Hans C. Volz;John C. Igwe;Benjamin Funke.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: